• Seeking Alpha

Press Release: EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study

Seeking Alpha / 8 hours ago 1 Views

EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study

Read more
  • Source:
  • GlobeNewswire - News about Public Companies
Previous post
TextMagic AS aktsionäride otsuse vastuvõtmine koosolekut kokku kutsumata
Next post
Communiqué de presse : EADV : Les résultats de l’étude de phase 2a montrent que le brivekimig de Sanofi est efficace dans le traitement de l’hidrosadénite suppurée

Comments

Just Posted

  • UPAY Announces Appointment of Richard K. Pellerin to Its Board of Directors

    3 hours from now

  • ESSO S.A.F. : RÉSULTATS CONSOLIDÉS DU PREMIER SEMESTRE 2025

    3 hours from now

  • RCI BANQUE: ISSUANCE OF EUR 400 MILLION PERPETUAL NON-CALL 5.5yr INAUGURAL ADDITIONAL Tier 1 NOTES

    3 hours from now

  • RCI BANQUE : ÉMISSION INAUGURALE DE 400 MILLIONS D’EUROS D’OBLIGATIONS PERPÉTUELLES ADDITIONAL TIER 1 NON-CALL 5,5 ANS

    3 hours from now

  • Ölgerðin Egill Skallagrímsson hf.: Útgáfa á víxlum - OLGERD260324

    3 hours from now

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Reviews

Categories

  • Seeking Alpha 1312

Categories

  • Seeking Alpha 1312

Pages

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Copyright News That Move � 2018. All Rights Reserved

  • Seeking Alpha
  • Trade Halts